Neuroscience News at Yale
The Kavli Institute for Neuroscience is pleased to announce the recipients of the 2026 Kavli Postdoctoral Fellowship.
- May 15, 2026
The Kavli Institute for Neuroscience is pleased to announce the recipients of the 2026 Kavli Innovative Teams Award.
- May 13, 2026
Pietro De Camilli always wanted to be a scientist. He has spent his career bridging cell biology and neuroscience.
- May 12, 2026
A neurotransmitter known to quiet activity in the brain can sometimes do the opposite, researchers find, offering implications for psychiatric treatment.
- May 12, 2026
A new study by Yale School of Medicine’s Departments of Anesthesiology and Neurology uncovers new insights which may change the way we describe being under anesthesia. The study reveals that being anesthetized may be more than simply being “put to sleep,” potentially carrying more similarities to being in a coma than we originally thought.
- May 01, 2026Source: Yale News
While scientists have identified hundreds of different genes that are associated with autism, a new Yale-led study suggests that the specific genes may be less important than the pathway they take to the brain.
- April 29, 2026
Oakleigh Folkes, PhD, from the laboratory of Yong-Hui Jiang, MD, PhD, in the Department of Genetics, and Dahae "Julia" Jun, PhD, from the laboratory of Emilia Favuzzi, PhD, in the Department of Neuroscience, have been selected to receive the 2026 Kavli Postdoctoral Award for Collaborative Excellence.
- April 21, 2026
The new Yale School of Medicine program, in collaboration with Yale Divinity School, is fostering spiritually informed conversations within psychiatry.
- April 16, 2026
Please join us on Tuesday, May 19, at 4 pm., in the Mary S. Harkness Auditorium for the eighth annual Perspectives of Women in Science Lectureship hosted by the MD-PhD Program and the Office of the Dean of YSM.
- April 08, 2026
Yong-Hui Jiang’s research has uncovered the biology of neurogenetic disorders like Angelman syndrome and autism. His genome-editing work could lead to targeted therapies.